Ampio Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ampio Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 43.6 %, a 21.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 43.6 +7.61 +21.2% Dec 31, 2023
Q3 2023 30.1 -10.8 -26.5% Sep 30, 2023
Q2 2023 30.5 -9.05 -22.9% Jun 30, 2023
Q1 2023 31.3 -7.32 -19% Mar 31, 2023
Q4 2022 36 +1.6 +4.66% Dec 31, 2022
Q3 2022 40.9 +10.5 +34.6% Sep 30, 2022
Q2 2022 39.6 +6.7 +20.4% Jun 30, 2022
Q1 2022 38.6 -1.64 -4.08% Mar 31, 2022
Q4 2021 34.3 -27.3 -44.3% Dec 31, 2021
Q3 2021 30.4 -66.6 -68.7% Sep 30, 2021
Q2 2021 32.9 -135 -80.4% Jun 30, 2021
Q1 2021 40.2 -112 -73.5% Mar 31, 2021
Q4 2020 61.7 -137 -69% Dec 31, 2020
Q3 2020 97 -120 -55.3% Sep 30, 2020
Q2 2020 168 -80.4 -32.4% Jun 30, 2020
Q1 2020 152 -1.41K -90.3% Mar 31, 2020
Q4 2019 199 +1.38K Dec 31, 2019
Q3 2019 217 +446 Sep 30, 2019
Q2 2019 248 +459 Jun 30, 2019
Q1 2019 1.56K +1.8K Mar 31, 2019
Q4 2018 -1.19K -892 -304% Dec 31, 2018
Q3 2018 -228 -432 -212% Sep 30, 2018
Q2 2018 -210 -327 -281% Jun 30, 2018
Q1 2018 -235 -302 -452% Mar 31, 2018
Q4 2017 -294 -338 -759% Dec 31, 2017
Q3 2017 204 +170 +495% Sep 30, 2017
Q2 2017 116 +89.4 +334% Jun 30, 2017
Q1 2017 66.7 +45.8 +219% Mar 31, 2017
Q4 2016 44.6 +28.6 +178% Dec 31, 2016
Q3 2016 34.3 +23.8 +227% Sep 30, 2016
Q2 2016 26.8 +20 +296% Jun 30, 2016
Q1 2016 20.9 +14.7 +236% Mar 31, 2016
Q4 2015 16 +9.66 +152% Dec 31, 2015
Q3 2015 10.5 +4.08 +63.7% Sep 30, 2015
Q2 2015 6.77 +0.19 +2.89% Jun 30, 2015
Q1 2015 6.24 -1.35 -17.8% Mar 31, 2015
Q4 2014 6.37 -2.63 -29.2% Dec 31, 2014
Q3 2014 6.4 -2.64 -29.2% Sep 30, 2014
Q2 2014 6.58 -2.78 -29.7% Jun 30, 2014
Q1 2014 7.59 -0.78 -9.32% Mar 31, 2014
Q4 2013 9 +0.77 +9.35% Dec 31, 2013
Q3 2013 9.05 +0.53 +6.23% Sep 30, 2013
Q2 2013 9.35 -1.85 -16.5% Jun 30, 2013
Q1 2013 8.37 -4.18 -33.3% Mar 31, 2013
Q4 2012 8.23 Dec 31, 2012
Q3 2012 8.51 Sep 30, 2012
Q2 2012 11.2 Jun 30, 2012
Q1 2012 12.6 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.